Version 5.4
Homo sapiens Protein: FRMD4A
Summary
InnateDB Protein IDBP-44043.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol FRMD4A
Protein Name FERM domain containing 4A
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000264546
InnateDB Gene IDBG-55477 (FRMD4A)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 3 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Experimentally validated
Total 3 [view]
Protein-Protein 3 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
Cellular Component
GO:0005856 cytoskeleton
Protein Structure and Domains
PDB ID
InterPro IPR000299 FERM domain
IPR018979 FERM, N-terminal
IPR018980 FERM, C-terminal PH-like domain
IPR019748 FERM central domain
IPR019749 Band 4.1 domain
IPR019750 Band 4.1 family
IPR021774 Protein of unknown function DUF3338
IPR029071 Ubiquitin-related domain
PFAM PF09379
PF09380
PF00373
PF11819
PRINTS PR00935
PIRSF
SMART SM00295
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q5T376
UniProt Splice Variant
Entrez Gene 55691
UniGene Hs.568818
RefSeq
HUGO HGNC:25491
OMIM
CCDS
HPRD 13553
IMGT
EMBL AC044781 AC069025 AL139405 AL157392 AL157896 AL365495 AL512660 AL607075 CH471072
GenPept EAW86277

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca